Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Rapid

K-Number: K213165 · 2022-02-08

Decision Date2022-02-08
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Rapid is a medical device manufactured by Ischemaview, Inc.. It received FDA 510(k) clearance on 2022-02-08 under approval number K213165. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Rapid?

Rapid is a medical device that received FDA 510(k) clearance on 2022-02-08. It is manufactured by Ischemaview, Inc.. The 510(k) number is K213165.

When was Rapid approved by the FDA?

Rapid received FDA 510(k) clearance on 2022-02-08, under approval number K213165.

What company makes Rapid?

Rapid is manufactured by Ischemaview, Inc..

What is the FDA product code for Rapid?

The FDA product code for Rapid is LLZ.

Other Devices by Ischemaview, Inc.

View all 20 devices →

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.